Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

Matza, Martha

Staff, The University of Texas MD Anderson Cancer Center, (713) 794-4524

Contact Information

Fax: (713) 794-4589

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer - Supplemental Pre-Validation Protocol 0 0
Early Detection of Urinary Bladder Cancer 0 0
Early Molecular Detection of Invasive Bladder Cancer by Urine Examination 0 0
Molecular Genetics of Urinary Bladder Carcinoma 0 0
A Methylation Panel for Bladder Cancer 0 0
Molecular Progression of Methylation in Bladder Cancer 0 0

Closed Protocols

Protocol Name Biomarkers Datasets
Methylation & Proteomics-Based Detection of Bladder Cancer 0 0

Publications

Publication Name PubMed ID Journal
Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease. 11526485 Oncogene
Amplification/overexpression of a mitotic kinase gene in human bladder cancer. 12208897 J. Natl. Cancer Inst.
Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. 11784863 Mol. Cell. Biol.
Interaction and feedback regulation between STK15/BTAK/Aurora-A kinase and protein phosphatase 1 through mitotic cell division cycle. 11551964 J. Biol. Chem.
Filling the void: urinary markers for bladder cancer risk and diagnosis. 11259458 J. Natl. Cancer Inst.
Mapping and genome sequence analysis of chromosome 5 regions involved in bladder cancer progression. 11454992 Lab. Invest.
Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. 11751381 Cancer Res.
Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy. 14713761 J. Urol.
Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer. 15390184 Genes Chromosomes Cancer
High-resolution whole-organ mapping with SNPs and its significance to early events of carcinogenesis. 15908911 Lab. Invest.
Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways. 15778693 Lab. Invest.
Focus on bladder cancer. 15324694 Cancer Cell
Genetic modeling of human urinary bladder carcinogenesis. 10719370 Genes Chromosomes Cancer

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Addresses

N/A

To update addresses, please visit the Data Management and Coordinating Center.

32nd SC Meeting
Thank you to everyone who made the 32nd EDRN Steering Committee meeting a success. The next event is the 10th EDRN Scientific Workshop from March 6-8, 2018 in Bethesda, MD. More information about this Workshop will be sent soon. Click here to view the flyer.
Announcement



EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.